Levulan Kerastick Topical Solution 20pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Levulan Kerastick: Topical solution (20%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

AMINOLEVULINIC ACID (a MEE noe LEV ue LIN ik AS id) is a light sensitizing drug that is used in photodynamic therapy (PDT). PDT is used to treat many types of skin conditions including actinic keratosis and certain types of skin cancer. PDT is a two-step process that requires application of a drug and then exposure to a certain type of light.

In-Depth Information

Levulan Kerastick 20% Topical Solution

NDC: 673080101
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Actinic Keratosis

Storage Information
Discard unused portion. Do not store for later use.
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Levulan Kerastick 20% Topical Solution

Reported Side Effects for Levulan Kerastick 20% Topical Solution

Bleeding Incidence:
2.0-4.0%*
Severity: MODERATE
Onset: EARLY
Dysesthesia Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Skin Ulcer Incidence:
2.0-14.0%*
Severity: MODERATE
Onset: DELAYED
Skin Ulcer Incidence:
2.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Vesicular Rash Incidence:
4.0-5.0%*
Severity: MILD
Onset: DELAYED
Unusual Skin Lightening Incidence:
22.0-36.0%*
Severity: MILD
Onset: DELAYED
Darkened Skin Patches Incidence:
22.0-36.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
35.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
99.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Levulan Kerastick

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5